PCSK9 and cirrhosis of liver: Accordingly, serum PCSK9 was 171 (99–418) ng/mL in the 37 HCV patients with liver cirrhosis and 235 (106–406) ng/mL in HCV patients without liver cirrhosis and was strongly reduced in patients with liver cirrhosis diagnosed by ultrasound (Figure 2F).